In:
Letters in Drug Design & Discovery, Bentham Science Publishers Ltd., Vol. 20 ( 2023-06-07)
Abstract:
Ubiquitin-specific protease 7 (USP7) is one of the most widely studied Deubiquitinating enzymes (DUBs). The protein level of USP7 is highly expressed in a variety of malignant cancers, which suggests that it is a prognostic marker of cancers and a potential drug target for oncotherapy. Objective: The aim of this study was to identify natural and effective USP7 inhibitors in order to understand the activation of the USP7/p53 pathway by natural inhibitors. Methods: In this study, the USP7 enzyme activity screening system and p53 luciferase reporter system were applied for the discovery of natural USP7 inhibitors targeting the catalytic active site. Molecular docking and molecular dynamics (MD) simulation revealed the combined mechanism between USP7 with gardenin B. Results: The gardenin B was screened from our home-lab natural products (160 flavonoids) and had cytotoxicity in HCT116 cells (IC50 = 46.28 ± 2.16μM). Preliminary in vitro studies disclosed its antiproliferative activity and activated p53 signaling pathway in HCT116 cells. We found that the complex formed by gardenin B and 5vsk (ledock score = -6.8645, MM/GBSA score = -53.349) had the optimal binding conformation. Moreover, the MD simulation showed that the π-π interactions between gardenin B with His461 and Phe409 and the hydrogen bonds interaction between gardenin B with Leu406 and Phe409 played an important role in maintaining the close binding of the complexes. Conclusion: In conclusion, gardenin B could be used as a natural product inhibitor of USP7 for further optimized design and development potential.
Type of Medium:
Online Resource
ISSN:
1570-1808
DOI:
10.2174/1570180820666230607102138
Language:
English
Publisher:
Bentham Science Publishers Ltd.
Publication Date:
2023
SSG:
15,3
